Integrated immunophenotypic and ProMisE molecular profiling as predictors of immune checkpoint inhibitor response in recurrent endometrial cancer.

Saved in:
Bibliographic Details
Title: Integrated immunophenotypic and ProMisE molecular profiling as predictors of immune checkpoint inhibitor response in recurrent endometrial cancer.
Authors: Katayama K; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan., Yoshikawa N; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan. n-yoshikawa@med.nagoya-u.ac.jp., Liu W; Department of Obstetrics and Gynecology Collaborative Research, Bell Research Center, Nagoya University Graduate School of Medicine, Nagoya, Japan., Nakamura K; Center for Low Temperature Plasma Sciences, Nagoya University, Furo-Cho, Chikusa, Nagoya, Japan., Hattori S; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan., Kubokawa M; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan., Iyoshi S; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan., Yoshida K; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan., Yoshihara M; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan., Nagao Y; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan., Tamauchi S; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan., Yokoi A; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan., Niimi K; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan., Shimizu Y; Department of Obstetrics and Gynecology, Fujita Health University School of Medicine, Toyoake, Japan., Kawai Y; Department of Obstetrics and Gynecology, Ogaki Municipal Hospital, Gifu, Japan., Utsumi F; Department of Obstetrics and Gynecology, Fujita Health University Bantane Hospital, Nagoya, Japan., Watanabe E; Department of Gynecologic Oncology, Aichi Cancer Center, Nagoya, Japan., Suzuki S; Department of Gynecologic Oncology, Aichi Cancer Center, Nagoya, Japan., Shibata K; Department of Obstetrics and Gynecology, Fujita Health University Bantane Hospital, Nagoya, Japan., Kajiyama H; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Tsurumai-Cho 65, Showa-Ku, Nagoya, 466-8550, Japan.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Jun 02. Date of Electronic Publication: 2026 Jun 02.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first